N-myc downstream regulated gene1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0/G1 phase

Cancer Letters

Volumn 310, Issue 1, 2011, Pages 25-34

  Akiba, Jun ^a   Murakami, Yuichi ^b   Noda, Masaki ^b   Watari, Kosuke ^b   Ogasawara, Sachiko ^a   Yoshida, Takafumi ^a   Kawahara, Akihiko ^c   Sanada, Sakiko ^a   Yasumoto, Makiko ^a   Yamaguchi, Rin ^a   Kage, Masayoshi ^c   Kuwano, Michihiko ^b   Ono, Mayumi ^b   Yano, Hirohisa ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KURUME UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cell cycle arrest; Cyclin dependent kinase 4; Hepatocellular carcinoma; NDRG1 Cap43; P21

Indexed keywords

CYCLIN DEPENDENT KINASE 4; MIMOSINE; N MYC DOWNSTREAM REGULATED GENE1 PROTEIN; PROTEIN P21; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CONTROLLED STUDY; GENETIC TRANSFECTION; GROWTH RATE; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL CYCLE PROTEINS; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; G0 PHASE; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, NUDE; MIMOSINE; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN;

EID: 79961123952     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.05.034     Document Type: Article

References (40)

1. Tanaka Y., Hanada K., Mizokami M., Yeo A.E., Shih J.W., Gojobori T., Alter H.J. A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc. Natl. Acad. Sci. USA 2002, 99:15584-15589.
2. Kudo M. Early detection and curative treatment of early-stage hepatocellular carcinoma. Clin. Gastroenterol. Hepatol. 2005, 3:144-148.
3. Kokame K., Kato H., Miyata T. Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis: GRP78/BiP and novel genes. J. Biol. Chem. 1996, 271:29659-29665.
4. Kurdistani S.K., Arizti P., Reimer C.L., Sugrue M.M., Aaronson S.A., Lee S.W. Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res. 1998, 58:4439-4444.
5. Zhou D., Salnikow K., Costa M. Cap43, a novel gene specifically induced by Ni2+ compounds. Cancer Res. 1998, 58:2182-2189.
6. Shimono A., Okuda T., Kondoh H. N-myc-dependent repression of ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant. Mech. Dev. 1999, 83:39-52.
7. Masuda K., Ono M., Okamoto M., Morikawa W., Otsubo M., Migita T., Tsuneyoshi M., Okuda H., Shuin T., Naito S., Kuwano M. Downregulation of Cap43 gene by von Hippel-Lindau tumor suppressor protein in human renal cancer cells. Int. J. Cancer 2003, 105:803-810.
8. Gomez-Casero E., Navarro M., Rodriguez-Puebla M.L., Larcher F., Paramio J.M., Conti C.J., Jorcano J.L. Regulation of the differentiation-related gene Drg-1 during mouse skin carcinogenesis. Mol. Carcinogen. 2001, 32:100-109.
9. Okuda T., Higashi Y., Kokame K., Tanaka C., Kondoh H., Miyata T. Ndrg1-deficient mice exhibit a progressive demyelinating disorder of peripheral nerves. Mol. Cell Biol. 2004, 24:3949-3956.
10. Chen B., Nelson D.M., Sadovsky Y. N-myc down-regulated gene 1 modulates the response of term human trophoblasts to hypoxic injury. J. Biol. Chem. 2006, 281:2764-2772.
11. Lachat P., Shaw P., Gebhard S., van Belzen N., Chaubert P., Bosman F.T. Expression of NDRG1, a differentiation-related gene, in human tissue. Histochem. Cell Biol. 2002, 118:399-408.
12. Bandyopadhyay S., Pai S.K., Gross S.C., Hirota S., Hosobe S., Miura K., Saito K., Commes T., Hayashi S., Watabe M., Watabe K. The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res. 2003, 63:1731-1736.
13. Bandyopadhyay S., Pai S.K., Hirota S., Hosobe S., Takano Y., Saito K., Piquemal D., Commes T., Watabe M., Gross S.C., Wang Y., Ran S., Watabe K. Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene 2004, 23:5675-5681.
14. Maruyama Y., Ono M., Kawahara A., Yokoyama T., Basaki Y., Kage M., Aoyagi S., Kinoshita H., Kuwano M. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. Cancer Res. 2006, 66:6233-6242.
15. Guan R.J., Ford H.L., Fu Y., Li Y., Shaw L.M., Pardee A.B. Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res. 2000, 60:749-755.
16. Shah M.A., Kemeny N., Hummer A., Drobnjak M., Motwani M., Cordon-Cardo C., Gonen M., Schwartz G.K. Drg1 expression in 131 colorectal liver metastases: correlation with clinical variables and patient outcomes. Clin. Cancer Res. 2005, 11:3296-3302.
17. Nishio S., Ushijima K., Tsuda N., Takemoto S., Kawano K., Yamaguchi T., Nishida N., Kakuma T., Tsuda H., Kasamatsu T., Sasajima Y., Kage M., Kuwano M., Kamura T. Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma. Cancer Lett. 2008, 264:36-43.
18. Chua M.S., Sun H., Cheung S.T., Mason V., Higgins J., Ross D.T., Fan S.T., So S. Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Mod. Pathol. 2007, 20:76-83.
19. Akiba J., Ogasawara S., Kawahara A., Nishida N., Sanada S., Moriya F., Kuwano M., Nakashima O., Yano H. N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma. Oncol. Rep. 2008, 20:1329-1335.
20. Yan X., Chua M.S., Sun H., So S. N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells. Cancer Lett. 2008, 262:133-142.
21. Kawahara A., Azuma K., Hattori S., Nakashima K., Basaki Y., Akiba J., Takamori S., Aizawa H., Yanagawa T., Izumi H., Kohno K., Kono S., Kage M., Kuwano M., Ono M. The close correlation between 8-hydroxy-2'-deoxyguanosine and epidermal growth factor receptor activating mutation in non-small cell lung cancer. Hum. Pathol. 2010, 41:51-959.
22. Yano H., Iemura A., Fukuda K., Mizoguchi H., Haramaki M., Kojiro M. Establishment of two distinct human hepatocellular carcinoma cell lines from a single nodule showing clonal dedifferentiation of cancer cells. Hepatology 1993, 18:320-327.
23. Hosoi F., Izumi H., Kawahara A., Murakami Y., Kinoshita H., Kage M., Nishio K., Kohno K., Kuwano M., Ono M. N-myc downstream regulated gene 1/Cap43 suppresses tumor growth and angiogenesis of pancreatic cancer through attenuation of inhibitor of kappaB kinase beta expression. Cancer Res. 2009, 69:983-4991.
24. KÜppers M., Ittrich C., Faust D., Dietrich C. The transcriptional programme of contact-inhibition. J. Cell. Biochem. 2010, 110:234-1243.
25. Ritt M.G., Mayor J., Wojcieszyn J., Smith R., Barton C.L., Modiano J.F. Sustained nuclear localization of p21/WAF-1 upon growth arrest induced by contact inhibition. Cancer Lett. 2000, 158:73-84.
26. Paradis V., Youssef N., Dargère D., Ba N., Bonvoust F., Deschatrette J., Bedossa P. Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas. Hum. Pathol. 2001, 32:327-332.
27. Lunz J.G., Tsuji H., Nozaki I., Murase N., Demetris A.J. An inhibitor of cyclin-dependent kinase, stress-induced p21Waf-1/Cip-1, mediates hepatocyte mito-inhibition during the evolution of cirrhosis. Hepatology 2006, 41:262-1271.
28. Wagayama H., Shiraki K., Yamanaka T., Sugimoto K., Ito T., Fujisawa K., Takase K., Nakano T. p21WAF1/CTP1 expression and hepatitis virus type. Dig. Dis. Sci. 2001, 46:74-2079.
29. Wiemann S.U., Satyanarayana A., Tsahuridu M., Tillmann H.L., Zender L., Klempnauer J., Flemming P., Franco S., Blasco M.A., Manns M.P., Rudolph K.L. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J. 2002, 16:35-942.
30. Marshall A., Rushbrook S., Davies S.E., Morris L.S., Scott I.S., Vowler S.L., Coleman N., Alexander G. Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection. Gastroenterology 2005, 128:33-42.
31. Lee J.S., Chu I.S., Heo J., Calvisi D.F., Sun Z., Roskams T., Durnez A., Demetris A.J., Thorgeirsson S.S. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 2004, 40:667-676.
32. Sherr C.J., Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999, 13:1501-1512.
33. Sherr C.J., Roberts J.M. Living with or without cyclins and cyclin-dependent kinases. Genes Dev. 2004, 18:2699-2711.
34. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell 1995, 81:323-330.
35. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 1998, 12:2245-2262.
36. Abbas T., Dutta A. p21 in cancer: intricate networks and multiple activities. Nat. Rev. Cancer 2009, 9:0-414.
37. Dong Z., Arnold R.J., Yang Y., Park M.H., Hrncirova P., Mechref Y., Novotny M.V., Zhang J.T. Modulation of differentiation-related gene 1 expression by cell cycle blocker mimosine, revealed by proteomic analysis. Mol. Cell Proteomics 2005, 4:993-1001.
38. Kulp K.S., Green S.L., Vulliet P.R. Iron deprivation inhibits cyclin-dependent kinase activity and decreases cyclin D/CDK4 protein levels in asynchronous MDA-MB-453 human breast cancer cells. Exp. Cell Res. 1996, 229:0-68.
39. Kitamura E., Hatano E., Higashi T., Masato N., Seo S., Nakamoto Y., Yamanaka K., Nagata H., Taura K., Yasuchika K., Nitta T., Uemoto S. Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis. J. Hepatol. 2011, 17. Epub ahead of print.
40. Murakami Y., Hosoi F., Izumi H., Maruyama Y., Ureshino H., Watari K., Kohno K., Kuwano M., One M. Identification of sites subjected to serine/threonine phosphorylation by SGK1 affecting N-myc downstream-regulated gene 1 (NDRG1)/Cap43-dependent suppression of angionenic CXC chemokine expression in human pancreatic cancer cells. Biochem. Biophys. Res. Commun. 2010, 396:376-381.